VQW-765
VP-VQW-765-3201
Phase 3 small_molecule active
Quick answer
VQW-765 for Social Anxiety Disorder (SAD) is a Phase 3 program (small_molecule) at Vanda Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vanda Pharmaceuticals
- Indication
- Social Anxiety Disorder (SAD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active